Advertisement

Patient Selection Process for the Harmony Transcatheter Pulmonary Valve Early Feasibility Study

      This early feasibility study was designed to obtain in vivo data to confirm assumptions on device loading conditions of the Medtronic Harmony transcatheter pulmonary valve (TPV). Secondary objectives included procedural feasibility, safety, and valve performance. The Harmony TPV was developed for nonsurgical pulmonary valve replacement in non–right ventricle-pulmonary artery conduit patients. The Native Outflow Tract TPV Research Clinical Study was the first study approved under the Food and Drug Administration Early Feasibility Study guidance. Enrollment required that patient anatomy be precisely matched to the single-size Harmony TPV implant, necessitating a rigorous selection process. The study was nonrandomized, prospective, and performed at 3 sites. All patients met standard indications for surgical pulmonary valve replacement. The goal of the screening committee was to match the candidate anatomy to predetermined engineering criteria thought to be predictive of secure Harmony TPV implantation for the single-size device under study. A majority of the screening committee was required to recommend a patient as eligible for implant. A total of 270 patients underwent prescreening cardiac magnetic resonance imaging, 66 were enrolled and received a computed tomography scan (24%), 21 met criteria for implant and were catheterized (8%), and 20 underwent implant. Nineteen of 20 met criteria for implant success. In conclusion, the Medtronic Harmony TPV represents an emerging therapeutic option for patients with complex postoperative right ventricular outflow tract failure. The initial clinical evaluation of this technology was unique, and the highly variable anatomy of this population required careful screening to ensure acceptable device fit.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Capelli C.
        • Taylor A.M.
        • Migliavacca F.
        • Bonhoeffer P.
        • Schievano S.
        Patient-specific reconstructed anatomies and computer simulations are fundamental for selecting medical device treatment: application to a new percutaneous pulmonary valve.
        Philos Trans A Math Phys Eng Sci. 2010; 368: 3027-3038
        • Schievano S.
        • Coats L.
        • Migliavacca F.
        • Norman W.
        • Frigiola A.
        • Deanfield J.
        • Bonhoeffer P.
        • Taylor A.M.
        Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation.
        J Cardiovasc Magn Reson. 2007; 9: 687-695
        • Schoonbeek R.C.
        • Takebayashi S.
        • Aoki C.
        • Shimaoka T.
        • Harris M.A.
        • Fu G.L.
        • Kim T.S.
        • Dori Y.
        • McGarvey J.
        • Litt H.
        • Bouma W.
        • Zsido 2nd, G.
        • Glatz A.C.
        • Rome J.J.
        • Gorman R.C.
        • Gorman 3rd, J.H.
        • Gillespie M.J.
        Implantation of the Medtronic harmony transcatheter pulmonary valve improves right ventricular size and function in an ovine model of postoperative chronic pulmonary insufficiency.
        Circ Cardiovasc Interv. 2016; 9
        • Cheatham J.P.
        • Bergersen L.
        • Gillespie M.J.
        • McHenry B.T.
        • Benson L.N.
        Initial results from the early feasibility study of the Medtronic native outflow tract transcatheter pulmonary valve [ACC abstract].
        J Am Coll Cardiol. 2016; 67: 929
        • Meadows J.J.
        • Moore P.M.
        • Berman D.P.
        • Cheatham J.P.
        • Cheatham S.L.
        • Porras D.
        • Gillespie M.J.
        • Rome J.J.
        • Zahn E.M.
        • McElhinney D.B.
        Use and performance of the melody transcatheter pulmonary valve in native and postsurgical, nonconduit right ventricular outflow tracts.
        Circ Cardiovasc Interv. 2014; 7: 374-380
        • Guccione P.
        • Milanesi O.
        • Hijazi Z.M.
        • Pongiglione G.
        Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN transcatheter heart valve.
        Eur J Cardiothorac Surg. 2012; 41: 1192-1194
        • Bergersen L.
        • Benson L.N.
        • Gillespie M.J.
        • Cheatham S.L.
        • Crean A.
        • Hor K.N.
        • Horlick E.
        • Lung T.
        • McHenry B.T.
        • Osten M.
        • Powell A.J.
        • Cheatham J.P.
        Harmony feasibility trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary valve.
        JACC Cardiovasc Interv. 2017; (In press)
        • US Food and Drug Administration
        Investigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human (FIH) Studies: Guidance for Industry and Food and Drug Administration Staff.
        US Department of Health and Human Services, Rockville, MD2013
        • McHenry B.T.
        Non-invasive evaluation of fit and sizing of device prior to implant.
        (inventor; Medtronic, Inc, assignee; US patent application 20150119692)2014